Effectiveness of ginger infusion as a complementary therapy to reduce blood pressure in 3-month injectable contraceptive acceptors
Keywords:
complementary therapy, ginger infusion, herbal, hypertension, injectable contraceptiveAbstract
Hypertension represents a prevalent non-communicable ailment within communities, frequently characterized as a "silent killer" owing to its subtle manifestations. Among the susceptible populations are individuals employing three-month injectable contraceptives, wherein progesterone may elevate bodily fluid retention. This investigation sought to assess the efficacy of ginger infusion (wedang jahe) in diminishing blood pressure levels among recipients of three-month injectable contraceptives at PMB Khusnul Khotimah in Pasuruan City. Employing a pre-experimental methodology with a one-group pretest-posttest framework, the study involved 32 participants recruited via purposive sampling. Participants ingested 4 grams of ginger steeped in 200 ml of warm water on a daily basis for seven successive days. Findings demonstrated a mean reduction in systolic blood pressure from 143 mmHg to 127 mmHg, alongside a decline in diastolic pressure from 91 mmHg to 82 mmHg. Statistical evaluation through the paired t-test produced a p-value of 0.000 (below 0.05), confirming a notable disparity between pre- and post-intervention measurements. Consequently, ginger infusion proved efficacious in lowering blood pressure for users of three-month injectable contraceptives, positioning it as a viable, accessible, and cost-effective non-pharmacological adjunct therapy within community midwifery settings.
References
Arablou, T., Aryaeian, N., Valizadeh, M., Sharifi, F., Hosseini, A., & Djalali, M. (2022). The effect of ginger consumption on blood pressure and metabolic profiles in adults: A systematic review and meta-analysis of randomized controlled trials. Phytotherapy Research, 36(4), 1501–1514. https://doi.org/10.1002/ptr.7381
Febriyanti, S., Ronoatmodjo, S., Helda, H., Riyadina, W., & Endarti, A. T. (2025). Hubungan penggunaan kontrasepsi hormonal dengan kejadian hipertensi pada wanita usia subur di Indonesia. Jurnal Kesehatan Tambusai, 6(2), 6707–6718.
Heshmati, J., & Namazi, N. (2020). Effects of ginger on cardiovascular risk factors in patients with metabolic syndrome: A systematic review. Complementary Therapies in Medicine, 52, 102494. https://doi.org/10.1016/j.ctim.2020.102494
Kementerian Kesehatan Republik Indonesia. (2023). Laporan Nasional Riskesdas 2023. Kementerian Kesehatan RI.
Luthfiyah, U., Runjati, R., & Anwar, M. C. (2023). Red ginger (Zingiber officinale var. rubrum) nanoparticle extracts on reducing blood pressure for postpartum hypertension. MEDISAINS: Jurnal Ilmiah Ilmu-Ilmu Kesehatan, 21(1), 1–8. https://doi.org/10.30595/medisains.v21i1.15165
Mahdavi-Roshan, M., Salari, A., Ghorbani, Z., & Ashouri, A. (2022). The effects of ginger supplementation on endothelial function and blood pressure: A randomized clinical trial. Journal of Herbal Medicine, 32, 100533. https://doi.org/10.1016/j.hermed.2022.100533
Mills, K. T., Stefanescu, A., & He, J. (2020). The global epidemiology of hypertension. Nature Reviews Nephrology, 16(4), 223–237. https://doi.org/10.1038/s41581-019-0244-2
Ramadan, M. F., Gad, H. A., & Farag, M. A. (2023). Bioactive compounds and cardiovascular protective effects of ginger: Recent updates and therapeutic perspectives. Food Bioscience, 53, 102673. https://doi.org/10.1016/j.fbio.2023.102673
Sari, N. P., Handayani, L., & Utami, D. R. (2022). Hypertension among injectable contraceptive users in primary healthcare settings in Indonesia. Belitung Nursing Journal, 8(5), 401–408. https://doi.org/10.33546/bnj.2203
van Rooyen, J. M., Poglitsch, M., Mels, C. M. C., Huisman, H. W., Gafane-Matemane, L. F., Le Roux, S., & Schutte, A. E. (2022). Aldosterone and angiotensin II profiles in young black and white women using different hormonal contraceptives: The African-PREDICT study. Journal of Human Hypertension, 36(8), 711–717. https://doi.org/10.1038/s41371-021-00569-6
World Health Organization. (2023). Hypertension fact sheet. World Health Organization
Yuniarti, T., & Rosyada, A. (2021). Hubungan antara penggunaan kontrasepsi hormonal dengan kejadian hipertensi pada wanita usia subur di Indonesia. Jurnal Kesehatan Masyarakat Indonesia, 16(4), 240–245. https://doi.org/10.26714/jkmi.16.4.2021.240-245
Zakiyah, N., Suciati, A., Afina, C. A., & Alfian, S. D. (2025). The use of oral contraceptives and the risks of developing prehypertension and hypertension in women of reproductive age: Findings from a population-based survey in Indonesia. BMC Public Health, 25(1), 1–12. https://doi.org/10.1186/s12889-025-22686-4
Zhou, Y., Wang, J., & Li, X. (2021). Hormonal contraceptives and cardiovascular risk factors: A systematic review and meta-analysis. Frontiers in Cardiovascular Medicine, 8, 695596. https://doi.org/10.3389/fcvm.2021.695596
Zhu, Y., Bo, Y., & Liu, Y. (2021). Dietary herbal interventions for hypertension management: Current evidence and future perspectives. Nutrients, 13(11), 3987. https://doi.org/10.3390/nu13113987
